DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2022 11.05.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2022 Berlin (Germany) and San Diego, CA (U.S.A.), May 11, […]
Category: Press Releases
24. March 2022
Epigenomics AG Reports Financial Results for Fiscal Year 2021
DGAP-News: Epigenomics AG / Key word(s): Annual Report/Annual Results24.03.2022 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for Fiscal Year 2021 Total revenue of EUR 6.2 million, adjusted EBITDA of EUR -1.8 million FDA clinical trial for Epi proColon “Next Gen” expected to start with […]
24. January 2022
Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon ‘Next-Gen’ Colorectal Cancer Screening Test
DGAP-News: Epigenomics AG / Key word(s): Personnel24.01.2022 / 07:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon “Next-Gen” Colorectal Cancer Screening Test Greg Hamilton retained as CEO through 2025 Appointment underscores Epigenomics’ commitment to the […]
14. December 2021
Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer
DGAP-News: Epigenomics AG / Key word(s): Personnel14.12.2021 / 07:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer Jens Ravens is an internationally experienced leader with in-depth experience in Controlling, Finance, M&A, IT, Legal, and Human Resources New Chief Financial Officer […]
18. November 2021
Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer
DGAP-News: Epigenomics AG / Key word(s): Personnel18.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer Dr. Andrew Lukowiak is a proven senior executive with deep technology and development expertise Appointment underscores Epigenomics’ commitment to the […]
10. November 2021
Epigenomics AG publishes financial results for the first nine months 2021
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results10.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first nine months 2021 Berlin (Germany) and San Diego, CA (U.S.A.), November 10, 2021 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the “Company”) today […]